Ioannis Tomos

Sotiria General Hospital — Greece

Medicine · Health Sciences

12h-index634citations96works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(32), Chronic Obstructive Pulmonary Disease (COPD) Research(10), Lung Cancer Diagnosis and Treatment(8), Occupational and environmental lung diseases(8), COVID-19 Clinical Research Studies(7)

Publications96 total

Versican expression from lung fibroblasts suppresses pulmonary fibrosis
Nature Communications·2026Open Access
Birt–Hogg–Dubé Syndrome: A Mini Review of the Clinical Manifestations, Investigation, and Management
Journal of Personalized Medicine·2025Open Access
Adult asthma in Greece: prevalence, comorbidities, and risk factors
Expert Review of Respiratory Medicine·2025
P252 Involvement of myeloid-derived suppressor cells in allergic airway diseases: preliminary results of a systematic review of the literature
2025
P251 Investigation of myeloid-derived suppressor cells as a biomarker for the differential diagnosis of lung diseases
2025
ELEVATE IPF PHASE 2B RESULTS (DEUPIRFENIDONE VS. PLACEBO AND PIRFENIDONE) IN PATIENTS AGED ≥75 COMPARED WITH <75 YEARS
CHEST Journal·2025
Late Breaking Abstract - ELEVATE IPF phase 2b open-label extension demonstrates durable efficacy of deupirfenidone
2025· 1 cited
Expression of activation markers of circulating neutrophils and eosinophils in stable bronchiectasis
2025
Adaptive immunity impairment in bronchiectasis: crosstalk of immunomodulatory cells and lymphocytes
2025
The impact of obesity on COPD development: unveiling the hidden risks
Expert Review of Respiratory Medicine·2025
Deupirfenidone Compared to Placebo and Pirfenidone in Idiopathic Pulmonary Fibrosis: ELEVATE IPF Phase 2b Trial
American Journal of Respiratory and Critical Care Medicine·2025· 2 cited
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis
Diagnostics·2025· 1 citedOpen Access
ERS Congress 2024: highlights from the Thoracic Oncology Assembly
ERJ Open Research·2025· 1 citedOpen Access
ERS Congress 2024: highlights from the Interstitial Lung Diseases Assembly
ERJ Open Research·2025· 1 citedOpen Access
Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study
Expert Review of Respiratory Medicine·2025· 1 cited
The prognostic role of lung ultrasound in hospitalised patients with COVID-19. Correlation with chest CT findings and clinical markers of severity
Expert Review of Respiratory Medicine·2025· 1 cited
Pharmacological targeting of ECM homeostasis, fibroblast activation and invasion for the treatment of pulmonary fibrosis
Expert Opinion on Therapeutic Targets·2025· 10 cited
SMARCA4 deficiency in small cell lung cancer: A case report and narrative review of the literature
Biomolecules and Biomedicine·2025· 1 citedOpen Access
Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients
Respiratory Research·2025· 7 citedOpen Access
Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The “Non-Steroid”, “Non-Interventional” Approach
Journal of Clinical Medicine·2025· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Effrosyni D. Manali(22), Anna Karakatsani(16), Stelios Loukides(14), Andriana Ι. Papaioannou(12), Spyros A. Papiris(11), Spyros Papiris(9), Ioanna Korbila(8), Τheodoros Karampitsakos(8), Ιlias Papanikolaou(8), Demosthenes Bouros(8), Αrgyris Τzouvelekis(7), Lykourgos Kolilekas(7), Periklis Tomos(7), Spyridon Papiris(7), Serafeim Chrysikos(6), Despoina Papakosta(6), Κατερίνα Αντωνίου(6), Vasiliki Apollonatou(6), Aris Spathis(5), Zoe Daniil(5)